Epidermal Growth Factor | CAS:62253-63-8

We serve Epidermal Growth Factor CAS:62253-63-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Epidermal Growth Factor

Chemical Name:Epidermal Growth Factor
CAS.NO:62253-63-8
Synonyms:Epidermal Growth Factor
 
Physical and Chemical Properties:
Molecular Formula C270H401N73O83S7
Molecular Weight 6221.96723999994
 
Specification:
Appearance:White to off-white powder
Assay:≥95.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Epidermal growth factor is a growth factor that stimulates cell growth, proliferation and differentiation by binding to its receptor EGFR.



Contact us for information like Epidermal Growth Factor chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Epidermal Growth Factor physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Epidermal Growth Factor Use and application,Epidermal Growth Factor technical grade,usp/ep/jp grade.


Related News: From the perspective of the corresponding formulation manufacturer, the drug substance needs to meet the requirements of impurities and stability. The production base must pass the international quality system certifications such as cGMP and EuGMP. At the same time, the drug substance company must have sufficient capacity.2-Bromo-5-fluoro-3-nitropyridine manufacturer The United Kingdom, for instance, is now warning against all but essential travel to mainland China, and is advising against all travel to Hubei province, where the outbreak was first reported.cyclohexanecarbaldehyde supplier The United Kingdom, for instance, is now warning against all but essential travel to mainland China, and is advising against all travel to Hubei province, where the outbreak was first reported.ethyl (2S,5R)-5-[(benzyloxy)amino]piperidine-2-carboxylate ethanedioate vendor Active pharmaceutical ingredients directly impact disease.Active pharmaceutical ingredients directly impact disease.